Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-01-04 @ 8:34 AM
Study NCT ID:
NCT01671904
Status:
COMPLETED
Last Update Posted:
2020-10-14
First Post:
2012-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-10
First Submit QC Date:
None
Study First Post Date:
2012-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-12
Last Update Post Date:
2020-10-14
Last Update Post Date Type:
ACTUAL